Kidney cancer, Renal cell cancer
Results
Phase 2
This trial compared 2 different orders (sequences) of having everolimus and sunitinib for kidney cancer that had spread to other parts of the body. It was for people who had the most common type of kidney cancer called renal cell cancer.
Recruitment start: 5 May 2010
Recruitment end: 17 May 2011
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Amit Bahl
NIHR Clinical Research Network: Cancer
Novartis
Last reviewed: 25 May 2015
CRUK internal database number: 4214
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
